Pioneers of mRNA win Nobel — plus our interview; Eli Lilly’s M&A, leadership shuffle; UniQure layoffs as gene therapy players adapt; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
Next week, John Carroll and Drew Armstrong will be hosting a group of biopharma leaders in London for conversations about the future of R&D in Europe. Get your EuroBio tickets now — and for those who are coming in person, I’ll be there with Reynald Castañeda and the rest of the UK crew.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.